BioCentury
ARTICLE | Financial News

EyeGate raises $22.6 million

January 9, 2010 12:53 AM UTC

EyeGate Pharmaceuticals Inc. (Waltham, Mass.) raised $22.6 million in a series D round led by new investor Natixis Private Equity. Emerging Capital, also a new investor, joined existing investors Vent...